TWOEquity · Weekly research terminal

6610

TWi Biotechnology, Inc.

TW Healthcare Biotechnology

Latest week
14 Aug 2026
Weekly close
27.15 TWD
Fair value
17.66 TWD
Next-week expectancy
Negative 44.22%
Crowd view
Current verdict No votes yet Be first to vote

Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

6610

TWi Biotechnology, Inc.

Healthcare Biotechnology

TWi Biotechnology, Inc., a clinical-stage biopharmaceutical company, develops and sells drugs for innate immunity-related diseases in Taiwan. The company development pipeline comprises AC-203, which is in Phase 2 clinical trial for various indications, including epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus; and AC- 1101, which is in Phase 1 trial for the treatment of vitiligo and preclinical stage for the treatment of atopic dermatitis, as well as granuloma annulare …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
5,646,177,280
Fair value reference
17.66
Next-week expectancy
Negative · 44.22%

Over the latest 12 completed weeks ending 2026-08-14, 6610 rose 0.74%, moving from 26.95 to 27.15. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -22.64 and has softened across the 12-week window. Market Dynamics is -0.55 on the latest week. Next-week expectancy is negative at 44.22% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
27.15
12-Week Change
0.74%
Trend Signal
Active
Next-Week Expectancy
Negative 44.22%
Signal Weeks
12 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
27.15
12-Week Change
0.74%
Trend Signal
Active
Next-Week Expectancy
Negative 44.22%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-22.64
Market Dynamics
-0.55

Over the latest 12 completed weeks ending 2026-08-14, 6610 rose 0.74%, moving from 26.95 to 27.15. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -22.64 and has softened across the 12-week window. Market Dynamics is -0.55 on the latest week. Next-week expectancy is negative at 44.22% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6696 Lin BioScience, Inc. TWO 14 Aug 2026 708.00 930.00 684.00 912.00 28.81%
7832 Intelligene TWO 14 Aug 2026 11.75 13.55 11.75 13.55 15.32%
6949 Pell Bio-Med Technology Co., Ltd. TAI 14 Aug 2026 943.00 1090.00 914.00 1070.00 13.47%
6848 RBC Bioscience Corporation TWO 14 Aug 2026 19.05 23.45 19.05 21.55 13.12%
4147 TaiMed Biologics Inc. TWO 14 Aug 2026 58.30 69.80 58.20 64.20 10.12%
6810 Bio Preventive Medicine Corp. TWO 14 Aug 2026 21.05 24.15 20.70 23.05 9.50%
7776 Anya TWO 14 Aug 2026 30.00 33.15 29.85 32.50 8.33%
6945 AP Biosciences, Inc. TWO 14 Aug 2026 99.00 116.50 99.00 104.50 5.56%
6492 Senhwa Biosciences, Inc. TWO 14 Aug 2026 37.50 39.65 36.90 38.80 3.47%
4732 NatureWise Biotech & Medicals Corporation TWO 14 Aug 2026 15.95 16.70 15.90 16.50 3.45%
7827 HanchorBio Inc. TAI 14 Aug 2026 156.00 164.50 153.50 161.00 3.21%
7773 FullHope TWO 14 Aug 2026 26.30 27.10 25.90 27.10 3.04%
4911 G&E Herbal Biotechnology Co., Ltd. TWO 14 Aug 2026 28.00 28.95 28.00 28.85 3.04%
7837 Creative TWO 14 Aug 2026 70.00 72.10 70.00 72.10 3.00%
7725 LabTurbo Biotech Corporation TWO 14 Aug 2026 21.70 22.30 21.70 22.30 2.76%
6589 EirGenix Inc. TAI 14 Aug 2026 50.20 52.90 50.00 51.50 2.59%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context